Thrive Capital Management (Pennsylvania)’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,132
Closed -$730K 179
2024
Q2
$730K Buy
+5,132
New +$592K 0.33% 91

Other funds holding ACLS

Thrive Capital Management (Pennsylvania)'s ACLS Position: Q3 2024 in Review

Thrive Capital Management (Pennsylvania) sold out of Axcelis (ACLS) in Q3 2024, closing a stake of 5,132 shares — an estimated $730K sold.

Thrive Capital Management (Pennsylvania) first reported a position in ACLS in Q2 2024 and held it in 1 quarter. The position peaked at $730K in Q2 2024. 368 funds tracked by Wall St. Rank hold ACLS as of Q3 2024.

  • Thrive Capital Management (Pennsylvania) reported no remaining Axcelis position as of Q3 2024 after selling out during the quarter.
  • Thrive Capital Management (Pennsylvania) sold 5,132 Axcelis shares in Q3 2024, an estimated $730K.
  • Thrive Capital Management (Pennsylvania) first reported a position in Axcelis in Q2 2024 and held it in 1 quarter.
  • Thrive Capital Management (Pennsylvania)'s Axcelis position peaked at $730K in Q2 2024.
  • 368 funds tracked by Wall St. Rank held Axcelis as of Q3 2024.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q3 2024, filed 13 Nov 2024.